LONDON,ENGLAND - MAY 30: A photo illustration of a Mounjaro pen on May 30 2025 in London, England. Mounjaro is a treatment for weight loss and type 2 diabetes. (Photo by Peter Dazeley via Getty Images ...

Eli Lilly’s (NYSE: LLY) first-quarter performance was mixed, with revenue meeting expectations but earnings falling short. The company reported adjusted earnings of $3.34 per share versus the ...

Eli Lilly and Company (NYSE:LLY) , which has been around since the late 1800s, has built a strong track record in developing and selling drugs for diabetes, cancer, and immunology, including ...

Eli Lilly (LLY) closed at $746.98 in the latest trading session, marking a -1.06% move from the prior day. This change lagged the S&P 500's daily loss of 0.55%. On the other hand, the Dow registered a ...

The move prompted Chief Market Strategist Shay Boloor of Futurum Equities to declare that a company like Lilly “doesn’t issue a 40-year bond unless they’re setting up for something BIG.” The ...

Eli Lilly and Company’s (LLY) new drug line-up is expected to generate higher revenues and earnings. Also, LLY’s robust earnings, favorable analyst estimates, and higher-than-industry profitability ...

Eli Lilly and Company (NYSE:LLY) is one of the Top 10 Stocks Wall Street is Buzzing About These Days. Talking about Morgan Stanley’s bullish call on Eli Lilly and Company (NYSE:LLY), Kevin Simpson, ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Carvana Co (Symbol: CVNA), where a total volume of 184,484 contracts has been ...